Multiparametric Magnetic Resonance Imaging in the Assessment of Anti-EGFRvIII Chimeric Antigen Receptor T Cell Therapy in Patients With Recurrent Glioblastoma

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0342-0